APA (7th ed.) Citation

Shen, L., Li, J., Xu, J., Pan, H., Dai, G., Qin, S., . . . Piao, Y. (2015). Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: Randomized, double-blind, phase III study (AVATAR study). Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 18(1), 168-176. https://doi.org/10.1007/s10120-014-0351-5

Chicago Style (17th ed.) Citation

Shen, Lin, et al. "Bevacizumab Plus Capecitabine and Cisplatin in Chinese Patients with Inoperable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer: Randomized, Double-blind, Phase III Study (AVATAR Study)." Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 18, no. 1 (2015): 168-176. https://doi.org/10.1007/s10120-014-0351-5.

MLA (9th ed.) Citation

Shen, Lin, et al. "Bevacizumab Plus Capecitabine and Cisplatin in Chinese Patients with Inoperable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer: Randomized, Double-blind, Phase III Study (AVATAR Study)." Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, vol. 18, no. 1, 2015, pp. 168-176, https://doi.org/10.1007/s10120-014-0351-5.